Peter Lucas, MD, Associate Professor of Pathology at the University of Pittsburgh and Director of Pathology and Principal Investigator at NSABP Foundation discusses the use of correlative science post-clinical trial and why clinical trials are important. (Interviewed October 2017 at the NSABP Foundation Annual Meeting in Chicago, IL.)

Thomas George, MD, Medical Director of GI Oncology Program at the University of Florida and a Principal Investigator with NSABP Foundation discusses his relationship with NSABP, clinical trials for MSI-high colorectal cancer patients, and the importance of clinical trials for colorectal cancer. (Interviewed October 2017 at the NSABP Annual Meeting in Chicago, IL.)

Shannon Puhalla, MD, discusses her role as a principal investigator for NSABP Foundation and the planning phases of the clinical study PALLET that uses palbociclib to help enhance breast cancer treatment. (Interviewed October 2017 at the NSABP Foundation Annual Meeting in Chicago, IL.)